Virginia Kaklamani, MD; Harold J. Burstein, MD, PhD

Article

Optimal Use of CDK4/6 Inhibitors in Breast Cancer

Author:: Virginia Kaklamani, MD; Harold J. Burstein, MD, PhD

Publish date: March 29, 2023

Leading oncologists discuss the role of CDK4/6 inhibitors in all stages of HR+/HER2- breast cancer, including robust results on the use of adjuvant...